semaglutide break Goes Generic: Big Pharma’s Moat Breaks How Semaglutide Helps Overcome Slow

The more frequent injection site reactions with exenatide once weekly (22%) compared with semaglutide (1.2%) in SUSTAIN-3 could be a consequence of this ( The head-to-head studies within the SUSTAIN and PIONEER programs allow some comparison of the adverse effect profile ( Table 2 )

Addressing the Injection Barrier: Why Oral Formulations Expand Treatment Access The shift toward oral GLP-1 formulations responds to well-documented barriers preventing substantial patient populations from accessing injectable metabolic therapies

Park J, Han S, Park H

Zinc above 40 mg daily is the threshold

Notably, GLP-1Rs have also been found in the atrial cavities and in the sinoatrial node, still their precise physiological function remains unclear (32)

It is important to have a comprehensive approach to cholesterol management